The cash flow of Vaxcyte, Inc. over the past 8 years
Chart Vaxcyte, Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2018–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Vaxcyte, Inc.'s operating cash flow was -$655.58M and its capital expenditures $13.71M, leaving free cash flow of -$669.29M. Free cash flow was below zero in all 8 years shown. It ranged from -$669.29M in fiscal 2025 to -$32.24M in fiscal 2018. Capital expenditures were highest in fiscal 2024, at $22.43M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$655.58M | $13.71M | -$669.29M |
| 2024ended Dec 31, 2024 | -$452.63M | $22.43M | -$475.05M |
| 2023ended Dec 31, 2023 | -$296.79M | $16.06M | -$312.85M |
| 2022ended Dec 31, 2022 | -$170.6M | $5.84M | -$176.44M |
| 2021ended Dec 31, 2021 | -$121.39M | $6.55M | -$127.95M |
| 2020ended Dec 31, 2020 | -$46.63M | $1.16M | -$47.78M |
| 2019ended Dec 31, 2019 | -$47.15M | $1.2M | -$48.34M |
| 2018ended Dec 31, 2018 | -$30.47M | $1.77M | -$32.24M |
Fiscal years as Vaxcyte, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Vaxcyte, Inc.
- The profitability of Vaxcyte, Inc.
- The debt of Vaxcyte, Inc.
- All of Vaxcyte, Inc.'s financials, charted
Companies of a similar size
- TWSTTwist Bioscience Corporation
- ZETAZeta Global Holdings Corp.
- HQYHEALTHEQUITY, INC.
- REXRRexford Industrial Realty, Inc.
- FLSFLOWSERVE CORP
Not investment advice. This page shows what Vaxcyte, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.